As summarized in Table 1 (see previous section), factors such as drug dose, duration of therapy, presence of diabetic gastroparesis, and type of endoscopic procedure play key roles
Thi gian s dng c th khc nhau ty thuc vo tnh trng da v mc tiu ca mi ngi, nhng cng cn c nhng khuyn co ring m bo sc khe
Evidence supporting the kidney and cardiovascular benefits of the GLP-1 receptor agonists comes from large clinical trials enrolling patients with type 2 diabetes, cardiovascular disease, chronic kidney disease (CKD), or a combination of these conditions (Figure 1)
Gives the skin a natural radiance and healthy glow that reflects inner care
Learn exactly how much to drink, which fluids count, and the red-flag dehydration signs that mean its time to call your doctor
Always start with a lower dose to see how your unique system responds